Standout Papers

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis 2020 2026 2022 2024515
  1. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis (2020)
    Richard Furie, Brad H. Rovin et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 56 standout
Sub-graph 1 of 20

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
2 intermediate papers

Works of Yulia Green being referenced

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
2020 Standout

Author Peers

Author Last Decade Papers Cites
Yulia Green 593 240 102 637 357 10 1.3k
Cándido Díaz‐Lagares 680 119 255 261 343 24 1.5k
G Sturfelt 747 149 34 221 568 21 1.1k
M J Cuadrado 868 100 81 251 415 21 1.5k
E. Chris Hagen 474 303 93 652 226 19 1.2k
Kathleen Maksimowicz‐McKinnon 858 297 25 903 603 32 1.6k
Roger Silvestrini 347 121 36 546 177 20 1.1k
R. Pérez-Álvarez 581 53 161 465 290 24 1.5k
Hélène Beaufils 475 615 106 285 146 24 1.1k
Fu Keung Li 563 669 204 230 203 19 1.3k
Nadia K. Tchao 257 125 148 600 769 29 1.7k

All Works

Loading papers...

Rankless by CCL
2026